Reinier Raymakers

Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial

Pieter Sonneveld, Ingo Schmidt‐Wolf, Bronno van der Holt et al. · Journal of Clinical Oncology · 2012 · 826 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Acquired mutations in TET2 are common in myelodysplastic syndromes

Saskia Langemeijer, Roland P. Kuiper, M Berends et al. · Nature Genetics · 2009 · 747 citations

Life Sciences, Genetics, Molecular Genetics +6

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

Régis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli et al. · New England Journal of Medicine · 2022 · 298 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

Rick Admiraal, Stefan Nierkens, Moniek A. de Witte et al. · The Lancet Haematology · 2017 · 213 citations · Full text

Medicine, Hematology, Immunology +17

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Hartmut Goldschmidt, H M Lokhorst, E K et al. · Leukemia · 2017 · 201 citations · Full text

Medicine, Hematology, Oncology +14